UBS Group’s General Moly, Inc. GMO Stock Holding History

UBS Group’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,100	Closed	-$2K	–	9640
2014 Q4	$2K	Buy	+3,100	New	+$1.75K	﹤0.01%	9451

Other funds holding GMO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

UBS Group's GMO Position: Q4 2020 in Review

UBS Group sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 28,525 shares — an estimated $3K sold.

UBS Group first reported a position in GMO in Q4 2014 and held it in 22 quarters. The position peaked at $19K in Q4 2018. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.

UBS Group reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
UBS Group sold 28,525 General Moly, Inc. shares in Q4 2020, an estimated $3K.
UBS Group first reported a position in General Moly, Inc. in Q4 2014 and held it in 22 quarters.
UBS Group's General Moly, Inc. position peaked at $19K in Q4 2018.
7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.